TLPH Soranni Sorafenib Tosylate 200mg

Product Information

• Product name: Soranni SORAFENIB TOSYLATE MG 200MG
• Manufacturer / brand: Laos TLPH Pharma
• Active ingredient: Sorafenib Tosylate
• Current strength: 200MG
• SKU: AM-ITEM-54
• Site category: general medicines, kidney cancer, liver cancer, thyroid cancer

Product Summary

Soranni SORAFENIB TOSYLATE MG 200MG is an AISTIKA-listed product supplied by Laos TLPH Pharma. This page summarizes the product identity, strength, SKU, site category, and public medical reference information. Product name, manufacturer, packaging, and strength follow this AISTIKA product page.

Active Ingredient and Reference Data

Sorafenib Tosylate is the active ingredient used for this product page. This product was not automatically matched to a public FDA/DailyMed label and should receive manual label review. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.

Mechanism of Action

Sorafenib Tosylate mechanism-of-action details were not available from an automatically matched public label in this batch. A clinician should verify the pharmacology from the current package insert or regulatory label before use.

Reference Indications

Reference indications could not be safely generated from an automatically matched public label. Indication, eligibility, and treatment setting must be confirmed by a physician using the current approved label and the patient’s clinical context.

Reference Dosage and Administration

A reliable public prescribing source was not automatically matched for this product. Reference dosage should be confirmed from the package insert, local prescribing information, and a physician or pharmacist before use.

This reference dosage is not an individualized prescription. Dose changes, treatment interruptions, or discontinuation must be directed by a physician.

Important Safety Information

Safety risks must be reviewed from the current package insert and by a healthcare professional. Prescription medicines may involve serious adverse reactions, contraindications, monitoring requirements, and drug interactions.

Common Adverse Reactions and Monitoring

Adverse reactions and laboratory monitoring requirements were not automatically matched for this product. Patients should be monitored according to the current label and clinician instructions, and should seek medical advice for new or worsening symptoms.

Drug Interactions and Special Populations

Drug interaction, pregnancy, lactation, renal impairment, hepatic impairment, pediatric, and geriatric considerations should be reviewed by a physician or pharmacist before use.

Storage and Purchase Notes

Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.

Sources

Sources: Manual review required; manual source review still required. These sources are used for public medical reference. Product information follows this AISTIKA product page.

DisclaimerThis page is for product information and public-label reference only. It does not provide diagnosis, prescription, or individualized medical advice. Consult a physician for treatment decisions.